{"id":9325,"date":"2026-05-05T20:38:00","date_gmt":"2026-05-05T13:38:00","guid":{"rendered":"https:\/\/www.globenewswire.com\/news-release\/2026\/05\/05\/3287883\/0\/en\/IBRX-Investors-Have-Opportunity-to-Lead-ImmunityBio-Inc-Securities-Fraud-Lawsuit-with-the-Schall-Law-Firm.html3287883"},"modified":"2026-05-05T20:42:23","modified_gmt":"2026-05-05T13:42:23","slug":"ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/","title":{"rendered":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm"},"content":{"rendered":"\n<p>LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8tIkK1KhlfSLUdjc7t1f_b8OzcU8ZzpYKNZFHwU0iJGj-7dAVqf6AUKg5Sia0YMsNBXqIYtDgt9EZ7O78kKtX3Tah1MChh2nNT8ksgqC_z0=\" rel=\"nofollow\" target=\"_blank\" title><u>The Schall Law Firm<\/u><\/a>, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jQVGNs6rCkqM3U9QsRELa2nqxIInNEs5zIi2EmqA9Lwr6F4QH8aOO2NWYOs1ndOWKa8nt_wJH9-IdagvHA-vTlARP9ObWMcStUHucgh0pdA=\" rel=\"nofollow\" target=\"_blank\" title=\"IBRX\">IBRX<\/a>) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n<p>Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to contact the firm before May 26, 2026.<\/p>\n<p>If you are a shareholder who suffered a loss, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6MqCwXn1yckIcZPNyPHNPqZBItqzdM4aZTavH37tooBDeu_cJArkpVRR1L3pAoSgH6fA8q7gw2K0MbyybzgBWb0V9KdN7twOpMIM_MdNJTxD8UbZZArbTh6saSTJpFHc7-_9xyGrNKevyHuygo9bIg==\" rel=\"nofollow\" target=\"_blank\" title=\"click here to participate\">click here to participate<\/a>.<\/p>\n<p>We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm&#8217;s website at&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vQ3bztJBs34NwCuWpQgQy5hzIWZ3lbJuQkbXjceR94vYBB176oP1aJhokzrRj0u04-choQfE_1-LRXYSGYn28oBERk6I_dVnW_a3zetSNE4=\" rel=\"nofollow\" target=\"_blank\" title><u>www.schallfirm.com<\/u><\/a>, or by email at&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3CdwCoC_ug71i_fCehpxtV9GBCkrbAmGfBIbxHlIgJzlyqvdYnpcyVx0hQqEejpXd6TTC2aQzLy_r7g1znWF7ae4mdhFnLzoTOxouSVEYE8=\" rel=\"nofollow\" target=\"_blank\" title=\"bschall@schallfirm.com\">bschall@schallfirm.com<\/a>.<\/p>\n<p>The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.<\/p>\n<p>According to the Complaint, the Company made false and misleading statements to the market. ImmunityBio overstated the capabilities of its Anktiva drug. Based on these facts, the Company\u2019s public statements were false and materially misleading throughout the class period. When the market learned the truth about ImmunityBio, investors suffered damages.<\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WtiuhRFi9DFws4rC9V0wzRiA_wpcQFTya3pIO4sb0ZLdfAu0z4Kt_MVXwxbxB7GzXB_uz9bSghA9PlwTSIFcGq7g88i1WaaAx7zexIcEYYun2pCfxjgyGOG4Tl9b0Y9UwHZUcn1TQ1aqkaJHMzTS-A==\" rel=\"nofollow\" target=\"_blank\" title=\"Join the case\">Join the case<\/a> to recover your losses<\/p>\n<p>The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p><strong>CONTACT:<\/strong><\/p>\n<p>The Schall Law Firm<br \/>Brian Schall, Esq.,<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vQ3bztJBs34NwCuWpQgQy-JAsOykPpSihJ1RMaXRnYFiUZiH1S2_Wrrt2kDtVK6vze-3M5FOcaeQ06vWj_DL7mURf-4E83J5phmGDM-dN1Q=\" rel=\"nofollow\" target=\"_blank\" title=\"www.schallfirm.com\">www.schallfirm.com<\/a><br \/>Office: 310-301-3335<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hMLtxqHygydwRSzAADFFcL7ZORlKg1QYkGFCtWFkcZ1_P-iZAYp2bMlsGRlkfFmPy__AcuqHzYyoRcx2fD-sI_ak8hi0WVgxp9RrGBNdDHE=\" rel=\"nofollow\" target=\"_blank\" title><u>info@schallfirm.com<\/u><\/a><\/p>\n<p><strong>SOURCE:<\/strong><\/p>\n<p>The Schall Law Firm<\/p>\n<p><img decoding=\"async\" alt src=\"https:\/\/ml.globenewswire.com\/media\/NzYxYjA2NTItODQ1Ni00Y2ZjLThmNTAtMDFlYmVjZTY2MjBjLTExMzU0MzMtMjAyNi0wNS0wNS1lbg==\/tiny\/Schall-Law.png\" referrerpolicy=\"no-referrer-when-downgrade\">  <\/p>\n","protected":false},"excerpt":{"rendered":"<p> LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) &#8212; The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":9326,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[75,1406],"tags":[],"class_list":["post-9325","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-globenewswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm<\/title>\n<meta name=\"description\" content=\"LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Crypto Insider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yourcryptoinsider\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T13:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-05T13:42:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/NzYxYjA2NTItODQ1Ni00Y2ZjLThmNTAtMDFlYmVjZTY2MjBjLTExMzU0MzMtMjAyNi0wNS0wNS1lbg==\/tiny\/Schall-Law.png\" \/>\n<meta name=\"author\" content=\"Crypto Insider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Crypto Insider\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/\"},\"author\":{\"name\":\"Crypto Insider\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\"},\"headline\":\"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm\",\"datePublished\":\"2026-05-05T13:38:00+00:00\",\"dateModified\":\"2026-05-05T13:42:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/\"},\"wordCount\":323,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif\",\"articleSection\":[\"Business\",\"GlobeNewswire\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/\",\"name\":\"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Crypto Insider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif\",\"datePublished\":\"2026-05-05T13:38:00+00:00\",\"dateModified\":\"2026-05-05T13:42:23+00:00\",\"description\":\"Crypto and Blockchain News\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif\",\"width\":1,\"height\":1},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Business\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/business\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"name\":\"Crypto Insider\",\"description\":\"Crypto and Blockchain News\",\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\",\"name\":\"Crypto Insider\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"width\":2048,\"height\":2048,\"caption\":\"Crypto Insider\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yourcryptoinsider\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vietnaminsider\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\",\"name\":\"Crypto Insider\",\"description\":\"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain\",\"sameAs\":[\"https:\\\/\\\/cryptoinsider.asia\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm","description":"LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to...","og_locale":"vi_VN","og_type":"article","og_title":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm","og_description":"LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or \u201cthe Company\u201d) (NASDAQ: IBRX) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d), are encouraged to...","og_url":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/","og_site_name":"Crypto Insider","article_publisher":"https:\/\/www.facebook.com\/yourcryptoinsider","article_published_time":"2026-05-05T13:38:00+00:00","article_modified_time":"2026-05-05T13:42:23+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/NzYxYjA2NTItODQ1Ni00Y2ZjLThmNTAtMDFlYmVjZTY2MjBjLTExMzU0MzMtMjAyNi0wNS0wNS1lbg==\/tiny\/Schall-Law.png","type":"","width":"","height":""}],"author":"Crypto Insider","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Crypto Insider","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"2 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#article","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/"},"author":{"name":"Crypto Insider","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6"},"headline":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm","datePublished":"2026-05-05T13:38:00+00:00","dateModified":"2026-05-05T13:42:23+00:00","mainEntityOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/"},"wordCount":323,"commentCount":0,"publisher":{"@id":"https:\/\/cryptoinsider.asia\/#organization"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/05\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif","articleSection":["Business","GlobeNewswire"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/","url":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/","name":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Crypto Insider","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/05\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif","datePublished":"2026-05-05T13:38:00+00:00","dateModified":"2026-05-05T13:42:23+00:00","description":"Crypto and Blockchain News","breadcrumb":{"@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#primaryimage","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/05\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/05\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif","width":1,"height":1},{"@type":"BreadcrumbList","@id":"https:\/\/cryptoinsider.asia\/vi\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cryptoinsider.asia\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/cryptoinsider.asia\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Business","item":"https:\/\/cryptoinsider.asia\/category\/business\/"},{"@type":"ListItem","position":4,"name":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/cryptoinsider.asia\/vi\/#website","url":"https:\/\/cryptoinsider.asia\/vi\/","name":"Crypto Insider","description":"Crypto and Blockchain News","publisher":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cryptoinsider.asia\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/cryptoinsider.asia\/vi\/#organization","name":"Crypto Insider","url":"https:\/\/cryptoinsider.asia\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","width":2048,"height":2048,"caption":"Crypto Insider"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yourcryptoinsider","https:\/\/www.linkedin.com\/company\/vietnaminsider"]},{"@type":"Person","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6","name":"Crypto Insider","description":"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain","sameAs":["https:\/\/cryptoinsider.asia"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2026\/05\/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-with-the-schall-law-firm.gif","jetpack-related-posts":[],"jetpack_likes_enabled":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/9325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/comments?post=9325"}],"version-history":[{"count":0,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/9325\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media\/9326"}],"wp:attachment":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media?parent=9325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/categories?post=9325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/tags?post=9325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}